2009
DOI: 10.1016/s0140-6736(09)60618-8
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
193
1
2

Year Published

2012
2012
2018
2018

Publication Types

Select...
3
2
2

Relationship

0
7

Authors

Journals

citations
Cited by 219 publications
(200 citation statements)
references
References 21 publications
4
193
1
2
Order By: Relevance
“…Although most patients with placental-site trophoblastic tumours can be cured, a substantial number of patients have recurrent disease. For such patients, Schmid et al reported that the outcome is poor with only 33% achieving long-term remission [6]. In this series, patients with stage I disease had a 10-year probability of overall survival of 90% and did not benefit from postoperative chemotherapy.…”
Section: Discussionmentioning
confidence: 67%
See 3 more Smart Citations
“…Although most patients with placental-site trophoblastic tumours can be cured, a substantial number of patients have recurrent disease. For such patients, Schmid et al reported that the outcome is poor with only 33% achieving long-term remission [6]. In this series, patients with stage I disease had a 10-year probability of overall survival of 90% and did not benefit from postoperative chemotherapy.…”
Section: Discussionmentioning
confidence: 67%
“…Thus, B-hCG appears to have no predictive value and disease may still progress even if levels are not raised. The range of serum B-hCG concentration at diagnosis in 69% is below 1000 IU/L [6]. The explanation of this moderated elevation of B-hCG is that these cells produce primarily more hPL and less B-hCG.…”
Section: Discussionmentioning
confidence: 95%
See 2 more Smart Citations
“…Typically, it occurs in women of reproductive age and may occur after any pregnancy (4). Although a majority of GTNs are extremely sensitive to chemotherapy, PSTT is relatively resistant to it (5). The purpose of this study was to present a 31-year-old case that presented to our clinic with complaints of irregular vaginal bleeding and was diagnosed with PSTT as a result of tests and examinations that were performed.…”
Section: Introductionmentioning
confidence: 99%